U.S. Software Stock News

NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte Shares Surge 20% as Analyst Upgrades Spark Fresh Valuation Debate

Wondering if Veracyte is offering real value right now? You're not alone, and with so much movement in health tech stocks, this could be a good moment to take a closer look. Veracyte shares have rallied recently, jumping 15.6% in the last week and up 19.8% for the past month, easily outpacing the broader market. The buzz isn't just about the price. A series of positive research collaborations and analyst upgrades are turning heads, giving fresh context to the recent...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx (GDRX): A Fresh Look at Valuation After Recent Share Price Decline

GoodRx Holdings (GDRX) has seen its stock under pressure lately, with a 29% drop over the past month. Investors are considering the company’s performance as they assess how recent trends in the healthcare discount space could impact future results. See our latest analysis for GoodRx Holdings. After a rocky few months, GoodRx Holdings’ downward momentum is hard to ignore. Despite brief rallies, the share price return year-to-date is down nearly 32%, and the one-year total shareholder return...
NasdaqGM:CCLD
NasdaqGM:CCLDHealthcare Services

CareCloud (CCLD): Evaluating Valuation After Recent 17% Share Price Jump

CareCloud (CCLD) shares have shown steady movement lately, with investors weighing recent performance trends. Over the past week, returns saw a sharp increase of 17%. In addition, the past 3 months delivered solid gains overall. See our latest analysis for CareCloud. Zooming out, CareCloud has seen momentum shift in recent months, with a 17% share price return over the past week helping to recover ground lost earlier in the year. Even so, the stock’s one-year total shareholder return sits at...
NYSE:INFA
NYSE:INFASoftware

Informatica (INFA): Assessing Valuation as Fundamentals and Market Sentiment Shift

Informatica (INFA) has been drawing some attention lately, as investors weigh its recent performance and underlying fundamentals. With a year-to-date return slightly negative and modest revenue growth, there is fresh debate about how the stock stacks up in the software sector. See our latest analysis for Informatica. Looking at the bigger picture, Informatica’s share price has drifted lower in recent months, reflecting a cautious mood after a period of modest gains. Despite this, its...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA): Is the Stock Overvalued After Recent Volatility?

Omada Health (OMDA) has been the subject of some investor attention lately. It is worth taking a closer look at how the company's stock has performed in the past month and what might be driving sentiment. See our latest analysis for Omada Health. Omada Health’s share price return has been volatile lately, dropping 17.3% over the last week alone and down 15.3% for the month, even as it remains up for the past quarter. Momentum appears to have faded in the short term, hinting at shifting...
NYSE:OPTU
NYSE:OPTUMedia

Optimum Communications (ATUS): Examining Valuation as Share Price Stabilizes After Steep Declines

Optimum Communications (NYSE:ATUS) shares saw subtle movement this week, offering investors fresh perspective on the company’s current valuation. With performance figures in hand, a closer inspection can reveal trends that may impact future expectations. See our latest analysis for Optimum Communications. After a period of sharp declines, Optimum Communications’ share price has shown only modest swings lately, even as the company navigates a shifting media landscape and ongoing operational...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV): Assessing Valuation Following Upbeat Earnings and Raised Revenue Guidance

Claritev (NYSE:CTEV) is in focus after announcing improved third-quarter results and raising full-year revenue guidance. The company reported stronger sales and sharply reduced losses, which signals momentum building into the second half of 2025. See our latest analysis for Claritev. The rally in Claritev’s stock has been hard to ignore; the share price closed at $69.25 after a one-day gain of 11.77%. The company now boasts a staggering year-to-date price return of 434.75%. These moves follow...